Literature DB >> 2452183

Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.

C J Boog1, J Boes, C J Melief.   

Abstract

Two class I MHC mutant mouse strains, bm14 and bm13, differ from the strain of origin B6 in one and three amino acids in the alpha 1 and alpha 2 domains of the H-2Db molecule, respectively. These alterations result in specific failure to generate a CTL (Tc) response to the male-specific Ag H-Y. Immunization and/or restimulation in vitro with syngeneic male dendritic cells (DC), expressing very high levels of class I MHC molecules, restored the H-Y-specific Tc response of bm14 but not of bm13 mice. Serologically Db determinants were lost in normal spleen cells of both mutants, because FACS analysis showed a decreased binding of Db domain-specific mAb. Although bm13 DC show a higher fluorescence than bm13 normal spleen cells it is still strongly reduced (30 to 50%) in comparison with B6 DC. Surprisingly, bm14 DC show an equally very strong binding compared with B6 DC with these mAb. The quantitative expression of class I molecules on APC thus appears to be a major determinant in the regulation of Tc responses. In addition, immunization with DC markedly influenced the target cell specificity of the ensuing Tc response. The combined data clearly demonstrate that besides the highly efficient class II-restricted presentation of Ag to Th, shown previously, DC are also superior in the presentation of Ag in the context of class I molecules to Tc. bm14 DC are capable of directly activating H-Y-specific Lyt-2+ Tc memory cells without the need for L3T4+ Th. These biologic effects of DC can at least in part be explained by their very high class I MHC expression. Moreover, these results reiterate that class I MHC Db mutants and different APC can be used to study the contribution of specific class I domains to Tc recognition and restriction specificity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452183

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.

Authors:  K E Peterson; M Iwashiro; K J Hasenkrug; B Chesebro
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.

Authors:  O Denis; E Lozes; K Huygen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

3.  The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies.

Authors:  J M Brewer; J Richmond; J Alexander
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice.

Authors:  B R Minev; B J McFarland; P J Spiess; S A Rosenberg; N P Restifo
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

5.  Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny.

Authors:  D E Speiser; H Pircher; P S Ohashi; D Kyburz; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

6.  The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.

Authors:  C McMenamin; P G Holt
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

7.  Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces.

Authors:  A S McWilliam; D Nelson; J A Thomas; P G Holt
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.